Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2001
08/16/2001WO2001059102A2 Nucleozymes with endonuclease activity
08/16/2001WO2001059095A1 Method of environmental purification or processing of harmful materials
08/16/2001WO2001059089A2 Improved galactosylation of recombinant glycoproteins
08/16/2001WO2001059086A2 Methods and constructs for agrobacterium-mediated plant transformation
08/16/2001WO2001059084A1 Protein c derivatives
08/16/2001WO2001059064A2 Nucleic acids, proteins, and antibodies
08/16/2001WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels
08/16/2001WO2001058945A1 Dna encoding human vanilloid receptor vr3
08/16/2001WO2001058944A1 Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof
08/16/2001WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES
08/16/2001WO2001058923A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation
08/16/2001WO2001058921A2 Methods and compositions for generating angiostatin
08/16/2001WO2001058916A2 Antibodies to ccr5
08/16/2001WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10
08/16/2001WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues
08/16/2001WO2001023416A3 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
08/16/2001WO2001011024A3 Bryostatins, bryopyrans and polyketides: compositions and methods
08/16/2001WO2001009347A3 Archaeal replication accessory factors and methods of use
08/16/2001WO2001009293A3 Mammalian adhesion protease peptides
08/16/2001WO2001009292A3 Sentrin-specific human proteases senp1-3
08/16/2001WO2001007628A3 Human synthetases
08/16/2001WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same
08/16/2001WO2001002569A3 Human immune response molecules
08/16/2001WO2000058352A3 Barley gene for thioredoxin and nadp-thioredoxin reductase
08/16/2001WO2000036093A9 Intein-mediated cyclization of peptides
08/16/2001WO2000006739A3 Chlamydia antigens and corresponding dna fragments and uses thereof
08/16/2001WO2000004156A3 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES)
08/16/2001US20010014673 Genetic engineering
08/16/2001US20010014672 High molecular weight major outer membrane protein of moraxella
08/16/2001US20010014668 Colonization factor antigens; epitopes; immunization against diarrheagenic Escherichia
08/16/2001US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell
08/16/2001US20010014471 Antitumor agents
08/16/2001US20010014464 Nucleic acid encoding follistatin-3
08/16/2001US20010014463 Lysozyme-like enzymes capable of killing cariogenic bacteria; also methods for studying the cell wall of oral bacterium, preventing spoilage of perishable items and removing dextrans from surfaces used in sugar refining
08/16/2001US20010014458 Human G-protein coupled receptor GPR6sb
08/16/2001US20010014444 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst
08/16/2001US20010014365 Applying hop extract to a food product or beverage to inhibit growth of Clostridium botulinum
08/16/2001US20010014332 Modified immunogenic pneumolysin compositions as vaccines
08/16/2001US20010014324 Agent for inducing resistance against phytopathogenic microorganisms in plants wherein the agent is an extract of biomass derived from biotechnological fermentation processes, from non-plant-pathogenic microorganisms
08/16/2001US20010014322 Comprising the bacteria Bifidobacterium bifidum 6-1 (CCTCC Number M 98003), Lactobacillus acidophilus YIT 2004 (CCTCC Number M 98004) and Streptococcus faecalis YIT 0027 (CCTCC Number M 98005); treating acute hepatitis, liver injuries
08/16/2001EP1123979A1 Process for producing coenzyme q 10?
08/16/2001EP1123976A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
08/16/2001EP1123975A1 Three-dimensional cell incubation media and method for incubating cells by using the same
08/16/2001EP1123661A1 Nitrogen containing composition on the basis of wheat gluten
08/16/2001EP1123501A1 Methods of concentrating microorganisms using affinity separation
08/16/2001EP1123409A2 Method of producing gamma-decalactone
08/16/2001EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
08/16/2001EP1123400A1 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect
08/16/2001EP1123399A2 Production and use of modified cystatins
08/16/2001EP1123397A2 G-protein coupled receptors
08/16/2001EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
08/16/2001EP1123393A1 Follistatin-related protein zfsta2
08/16/2001EP1123392A1 Prv-1 gene and the use thereof
08/16/2001EP1123391A2 Methods for improving the function of heterologous g protein-coupled receptors
08/16/2001EP1123389A1 A method of affinity separation and ligands for use therein
08/16/2001EP1123386A1 Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase
08/16/2001EP1123315A1 Multiple domain glycoprotein hormones and methods of using
08/16/2001EP1123314A2 USE OF A CYTOKINE-PRODUCING $i(LACTOCOCCUS) STRAIN TO TREAT COLITIS
08/16/2001EP1123313A2 Methods and compositions for the prevention and treatment of anemia
08/16/2001EP1123312A2 Human rna binding proteins
08/16/2001EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor
08/16/2001EP1123306A1 Inhibitors of platelet activation and recruitment
08/16/2001EP1123108A1 Isolated peptides which bind to hla-b35 molecules
08/16/2001EP0914192B1 Process for the purification of gases containing hydrogen sulphide
08/16/2001EP0731843B1 Tyrosinase-activator protein fusion enzyme
08/16/2001EP0576483B1 Biocidal proteins
08/16/2001DE10006201A1 New genes involved in oxidation of reduced sulfur compounds, particularly conversion of thiosulfate to sulfate, and related proteins, from Paracoccus pantotrophus
08/16/2001DE10005114A1 Verfahren zur Biomasse-Rückhaltung bei Biogasreaktoren sowie Vorrichtung zur Durchführung des Verfahrens A process for the biomass retention in biogas reactors, and device for carrying out the method
08/16/2001DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use
08/16/2001CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001CA2412143A1 Transgenic cells expressing glucosyltransferase nucleic acids
08/16/2001CA2400509A1 Regulated expression of plac in staphylococcus aureus
08/16/2001CA2400497A1 Methods and compositions for generating angiostatin
08/16/2001CA2400472A1 Il-17 like molecules and uses thereof
08/16/2001CA2400299A1 Dna encoding human vanilloid receptor vr3
08/16/2001CA2400187A1 Protein c derivatives
08/16/2001CA2399945A1 Larynx carcinoma-associated protein larcap-1
08/16/2001CA2399873A1 Drug metabolizing enzymes
08/16/2001CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
08/16/2001CA2399593A1 Antibodies to ccr5
08/16/2001CA2399266A1 Improved galactosylation of recombinant glycoproteins
08/16/2001CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using
08/16/2001CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same
08/16/2001CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/16/2001CA2398750A1 Nucleozymes with endonuclease activity
08/16/2001CA2392450A1 Nucleic acids, proteins, and antibodies
08/16/2001CA2368681A1 Anti-angiogenic intestinal peptides, zdint5
08/15/2001CN1308682A Fermentation process to produce clavulanic acid at a low concentration of free amino acids
08/15/2001CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
08/15/2001CN1308678A Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use
08/15/2001CN1308677A Human tumour-derived polyptde hormone phosphatonin
08/15/2001CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain
08/15/2001CN1308669A Dried microorganism cultures and method for producing same
08/15/2001CN1308125A Nucleotide sequence coding pck gene
08/15/2001CN1308124A Preparation and application of antibiotic peptide beer yeast
08/15/2001CN1308123A Preparation and application of antibiotic peptide pichia yeast
08/15/2001CN1307902A Varicella preventing method using vaccine
08/15/2001CN1307819A Composite feed for simple-stomach farm animal
08/15/2001CN1069698C Fungi hypha regenerating regulator